Patent Ductus Arteriosus: Are Current Neonatal Treatment Options Better or Worse Than No Treatment at All?
- 1 April 2012
- journal article
- review article
- Published by Elsevier BV in Seminars in Perinatology
- Vol. 36 (2), 123-129
- https://doi.org/10.1053/j.semperi.2011.09.022
Abstract
No abstract availableKeywords
This publication has 173 references indexed in Scilit:
- Target Ranges of Oxygen Saturation in Extremely Preterm InfantsNew England Journal of Medicine, 2010
- Early Surgical Ligation Versus a Conservative Approach for Management of Patent Ductus Arteriosus That Fails to Close after Indomethacin TreatmentThe Journal of Pediatrics, 2010
- The Role of Patent Ductus Arteriosus Ligation in Bronchopulmonary Dysplasia: Reexamining a Randomized Controlled TrialThe Journal of Pediatrics, 2009
- Arabidopsis COP1 shapes the temporal pattern of CO accumulation conferring a photoperiodic flowering responseThe EMBO Journal, 2008
- Patent Ductus Arteriosus: Evidence for and against TreatmentThe Journal of Pediatrics, 2007
- SKB1-mediated symmetric dimethylation of histone H4R3 controls flowering time in ArabidopsisThe EMBO Journal, 2007
- The Arabidopsis thaliana vernalization response requires a polycomb-like protein complex that also includes VERNALIZATION INSENSITIVE 3Proceedings of the National Academy of Sciences, 2006
- LUX ARRHYTHMO encodes a Myb domain protein essential for circadian rhythmsProceedings of the National Academy of Sciences, 2005
- The ELF4 gene controls circadian rhythms and flowering time in Arabidopsis thalianaNature, 2002
- GIGANTEA: a circadian clock-controlled gene that regulates photoperiodic flowering in Arabidopsis and encodes a protein with several possible membrane-spanning domainsThe EMBO Journal, 1999